Back to discover
Drug

Triglycerides

In clinical development
Actively researchedIn clinical testingRising momentum
26
Research papers
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this drug.

Metabolic characteristics of obese patients with polycystic ovarian syndrome: a meta-analysis.

Research2023-12-01Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology

Effect of Elevated Plasma-Free-Fatty-Acids on Renal Hemodynamic Parameters

Clinical trial2000-06-01Completed · ClinicalTrials.gov

Profile

Identifiers & mechanism

Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.

Canonical name
Triglycerides
RxNorm CUI
10808

Clinical trials

1 trials

The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.

Development programme
CLINICALTRIALS.GOV · LIVE REGISTRY
1
registered trials across all phases
LATEST COMPLETION 2000
1
Late-stage (III+)
1
Completed
PHASE DISTRIBUTIONn = 1
Phase N / A1

Recent completions

Trials that read out recently, adding to the completed evidence base.

Research activity

26 papers

Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.

Publications over time
19962025
Most influential
Recent papers
Major research themes8
Cardiovascular Diseases6Insulin Resistance4Triglycerides4Biomarkers3Blood Glucose2Body Mass Index2Cholesterol, HDL2Metabolic Syndrome2
Journals, researchers & institutions
Top journals
  • Cardiovascular diabetology7
  • The Journal of clinical investigation4
  • Gut2
  • The New England journal of medicine2
  • Arteriosclerosis, thrombosis, and vascular biology1
  • Cell metabolism1
Leading researchers
  • Després JP2
  • Ginsberg HN2
  • Li J2
  • Liu Z2
  • Zhang Y2
  • Zhou X2
  • Agrawal R1
  • Aihara E1
Leading institutions
free-text, unnormalised
  • Academic Medical Center1
  • Amsterdam Public Health Research Institute1
  • Amsterdam Reproduction and Development Research Institute1
  • and Einthoven Laboratory for Experimental Vascular Medicine1
  • Baylor College of Medicine1
  • Brigham and Women's Hospital1

Related diseases

8 conditions

Regulator-approved indications and conditions co-mentioned with this drug across the research literature. Number shows shared papers.

Related drugs

8 matches

Drugs sharing diseases, protein targets and literature with this one. Ranked by graph evidence (shared targets + diseases weighted above co-mentions).

Studied across 19 of the same disease areas as Triglycerides in the shared literature.

19 shared diseases4 shared papers

Studied across 7 of the same disease areas as Triglycerides in the shared literature.

7 shared diseases2 shared papers

Studied across 7 of the same disease areas as Triglycerides in the shared literature.

7 shared diseases1 shared paper

Studied across 6 of the same disease areas as Triglycerides in the shared literature.

6 shared diseases1 shared paper

Studied across 4 of the same disease areas as Triglycerides in the shared literature.

4 shared diseases2 shared papers

Studied across 5 of the same disease areas as Triglycerides in the shared literature.

5 shared diseases1 shared paper

Studied across 3 of the same disease areas as Triglycerides in the shared literature.

3 shared diseases1 shared paper

Studied across 3 of the same disease areas as Triglycerides in the shared literature.

3 shared diseases1 shared paper
References & data sources
  • RxNorm (U.S. National Library of Medicine) — drug identity
  • Europe PMC — research literature
  • ClinicalTrials.gov — clinical trials